Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000187

Chairperson & CEO sold 9,500 shares at an average $593.99 ($5,642,870)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

15 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-11 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-11-11 Sale : show line 2 in the form 10b5-1 −25 $584.20 $14,605 333,918 I
2026-11-11 Sale : show line 3 in the form 10b5-1 −215 $585.93 $125,976 333,703 I
2026-11-11 Sale : show line 4 in the form 10b5-1 −320 $586.59 $187,709 333,383 I
2026-11-11 Sale : show line 5 in the form 10b5-1 −271 $588.16 $159,391 333,112 I
2026-11-11 Sale : show line 6 in the form 10b5-1 −292 $589.18 $172,040 332,820 I
2026-11-11 Sale : show line 7 in the form 10b5-1 −301 $590.31 $177,684 332,519 I
2026-11-11 Sale : show line 8 in the form 10b5-1 −736 $591.56 $435,389 331,783 I
Open-market sales · 9,500 sh · avg $593.99 · $5,642,870

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-11 Exercise or conversion : show line 16 in the form 10b5-1 Stock Option −9,500 43,410 I
Loading xslF345X06/primarydocument.xml…